June 14, 2022 / 01:42 PM IST
Reported Consolidated quarterly numbers for Lincoln Pharmaceuticals are:Net Sales at Rs 102.59 crore in March 2022 up 28.91% from Rs. 79.58 crore in March 2021.
Story continues below Advertisement
Quarterly Net Profit at Rs. 11.02 crore in March 2022 down 12.32% from Rs. 12.57 crore in March 2021.
EBITDA stands at Rs. 19.34 crore in March 2022 up 8.77% from Rs. 17.78 crore in March 2021.
Lincoln Pharma EPS has decreased to Rs. 5.50 in March 2022 from Rs. 6.29 in March 2021.
Lincoln Pharma shares closed at 303.90 on June 13, 2022 (BSE)
| Lincoln Pharmaceuticals | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'22 | Mar'21 | Jun'20 | | Net Sales/Income from operations | 102.59 | 79.58 | 103.79 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 102.59 | 79.58 | 103.79 | | EXPENDITURE | | Consumption of Raw Materials | 43.63 | 25.01 | 27.02 | | Purchase of Traded Goods | 8.38 | 5.10 | 16.80 | | Increase/Decrease in Stocks | -6.58 | -5.08 | 7.17 | | Power & Fuel | -- | -- | -- | | Employees Cost | 17.28 | 20.39 | 12.92 | | Depreciation | 2.00 | 1.89 | 1.88 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 22.42 | 18.91 | 17.71 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 15.45 | 13.35 | 20.29 | | Other Income | 1.89 | 2.53 | 1.80 | | P/L Before Int., Excpt. Items & Tax | 17.34 | 15.89 | 22.09 | | Interest | 0.57 | 0.57 | 0.67 | | P/L Before Exceptional Items & Tax | 16.77 | 15.31 | 21.41 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 16.77 | 15.31 | 21.41 | | Tax | 5.75 | 2.73 | 6.15 | | P/L After Tax from Ordinary Activities | 11.02 | 12.58 | 15.26 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 11.02 | 12.58 | 15.26 | | Minority Interest | -- | -0.01 | 0.00 | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 11.02 | 12.57 | 15.26 | | Equity Share Capital | 20.03 | 20.00 | 20.00 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 5.50 | 6.29 | 7.63 | | Diluted EPS | 5.50 | 6.29 | -- | | EPS After Extra Ordinary | | Basic EPS | 5.50 | 6.29 | 7.63 | | Diluted EPS | 5.50 | 6.29 | -- | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
